Free Trial

Meeder Asset Management Inc. Has $476,000 Stake in UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group logo with Medical background

Meeder Asset Management Inc. cut its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 82.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 814 shares of the healthcare conglomerate's stock after selling 3,878 shares during the quarter. Meeder Asset Management Inc.'s holdings in UnitedHealth Group were worth $476,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Kathleen S. Wright Associates Inc. acquired a new position in UnitedHealth Group in the 3rd quarter worth about $27,000. Macroview Investment Management LLC increased its stake in shares of UnitedHealth Group by 671.4% during the 2nd quarter. Macroview Investment Management LLC now owns 54 shares of the healthcare conglomerate's stock worth $28,000 after purchasing an additional 47 shares during the last quarter. Bbjs Financial Advisors LLC bought a new stake in UnitedHealth Group in the second quarter worth $31,000. Global Wealth Strategies & Associates boosted its holdings in shares of UnitedHealth Group by 152.4% during the 3rd quarter. Global Wealth Strategies & Associates now owns 53 shares of the healthcare conglomerate's stock worth $31,000 after buying an additional 32 shares during the period. Finally, Signature Resources Capital Management LLC increased its position in UnitedHealth Group by 40.0% in the 2nd quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate's stock worth $32,000 after buying an additional 18 shares during the period. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the stock. Hsbc Global Res cut shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Thursday, October 17th. KeyCorp started coverage on UnitedHealth Group in a research report on Friday, October 11th. They issued an "overweight" rating and a $675.00 target price for the company. HSBC downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Thursday, October 17th. StockNews.com downgraded shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research note on Wednesday. Finally, Truist Financial restated a "buy" rating and issued a $625.00 target price (down from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Four analysts have rated the stock with a hold rating, seventeen have assigned a buy rating and two have given a strong buy rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $615.53.

Get Our Latest Analysis on UnitedHealth Group

UnitedHealth Group Stock Up 4.1 %

NYSE UNH traded up $23.50 during trading hours on Wednesday, hitting $600.50. 3,921,374 shares of the company traded hands, compared to its average volume of 3,880,279. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The stock has a market capitalization of $552.63 billion, a price-to-earnings ratio of 37.59, a P/E/G ratio of 1.74 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The business's 50-day moving average is $582.31 and its 200-day moving average is $551.25.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share for the quarter, topping analysts' consensus estimates of $7.00 by $0.15. The company had revenue of $100.82 billion during the quarter, compared to the consensus estimate of $99.14 billion. UnitedHealth Group had a return on equity of 26.37% and a net margin of 3.63%. The company's revenue was up 9.2% on a year-over-year basis. During the same quarter last year, the firm earned $6.56 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 27.6 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be paid a $2.10 dividend. The ex-dividend date is Monday, December 9th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.40%. UnitedHealth Group's payout ratio is currently 54.72%.

UnitedHealth Group Company Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Featured Articles

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

→ Tesla Execs are Freaking Out (From Angel Publishing) (Ad)

Should you invest $1,000 in UnitedHealth Group right now?

Before you consider UnitedHealth Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.

While UnitedHealth Group currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines